Dr. Buster serves as Chairman for Americas Gynecologist, which is a state of the art medical, genetic, and reproductive technology information resource directed to the interests of accomplished professional women. Dr Buster also serves as Director and consultant for a number of leading pharmaceutical and medical device companies.Dr. Buster has published over 250 original articles, book chapters, and reviews on subjects ranging from advanced methods of treating infertile women, pregnancy loss, menopause and menopause hormone replacement therapy, female sexual dysfunction and pre-implantation genetics. Dr. Buster serves as a reviewer for many medical journals, holds memberships in several academic societies and served as an examiner for the American Board of Obstetrics & Gynecology. He personally trained over 20 Reproductive Endocrinology fellows who ultimately practiced their specialty.Dr. Buster’s research has led to several historical innovations that have become standard medical practice. To date, his most significant work was directing the research team that led to the first embryo donation and birth in 1984. Most recently it was directing the effort leading to the first preimplantation testing (PGT) of human in vivo conceived embryos in history reported at ESHRE in July 2018.Dr. Buster is highly recognized for his contributions to woman's health, In 2012 the UCLA Biomedical Research named him a "Living Legend". In 2014, he was awarded an Endowed Lectureship by the American College of Obstetricians and Gynecologists titled "Cutting Edge Reproductive Technology". In 2017, Dr. Buster was inducted into the hall of fame for the American College of Obstetrics and Gynecologists. During his tenure with Women & Infants and Tufts Medical Center, Dr. Buster was cited by many organizations for his clinical expertise including: Best Doctors in America, US News Top Docs, Best 401 Doctors for Woman, and America's Top Gynecologists.